Barboza-Argüello María de la Paz, Umaña-Solís Lila M, Azofeifa Alejandro, Valencia Diana, Flores Alina L, Rodríguez-Aguilar Sara, Alfaro-Calvo Thelma, Mulinare Joseph
Unidad de Enfermedades Congénitas, Centro de Registro de Enfermedades Congénitas (CREC), Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (INCIENSA), Tres Ríos, Cartago, Costa Rica,
Matern Child Health J. 2015 Mar;19(3):583-90. doi: 10.1007/s10995-014-1542-8.
Our aim was to provide a descriptive overview of how the birth defects surveillance and folic acid fortification programs were implemented in Costa Rica-through the establishment of the Registry Center for Congenital Anomalies (Centro de Registro de Enfermedades Congénitas-CREC), and fortification legislation mandates. We estimated the overall prevalence of neural tube defects (i.e., spina bifida, anencephaly and encephalocele) before and after fortification captured by CREC. Prevalence was calculated by dividing the total number of infants born with neural tube defects by the total number of live births in the country (1987-2012).A total of 1,170 newborns with neural tube defects were identified from 1987 to 2012 (1992-1995 data excluded); 628 were identified during the baseline pre-fortification period (1987-1991; 1996-1998); 191 during the fortification period (1999-2002); and 351 during the post-fortification time period (2003-2012). The overall prevalence of neural tube defects decreased from 9.8 per 10,000 live-births (95 % CI 9.1-10.5) for the pre-fortification period to 4.8 per 10,000 live births (95 % CI 4.3-5.3) for the post-fortification period. Results indicate a statistically significant (P < 0.05) decrease of 51 % in the prevalence of neural tube defects from the pre-fortification period to the post-fortification period. Folic acid fortification via several basic food sources has shown to be a successful public health intervention for Costa Rica. Costa Rica's experience can serve as an example for other countries seeking to develop and strengthen both their birth defects surveillance and fortification programs.
我们的目标是通过建立先天性异常登记中心(Centro de Registro de Enfermedades Congénitas - CREC)以及强化立法规定,对哥斯达黎加如何实施出生缺陷监测和叶酸强化计划进行描述性概述。我们估计了CREC记录的强化前后神经管缺陷(即脊柱裂、无脑儿和脑膨出)的总体患病率。患病率通过将患有神经管缺陷的婴儿总数除以该国的活产总数(1987 - 2012年)来计算。1987年至2012年期间共识别出1170例患有神经管缺陷的新生儿(不包括1992 - 1995年的数据);在强化前基线期(1987 - 1991年;1996 - 1998年)识别出628例;在强化期(1999 - 2002年)识别出191例;在强化后期(2003 - 2012年)识别出351例。神经管缺陷的总体患病率从强化前期的每10000例活产9.8例(95%可信区间9.1 - 10.5)降至强化后期的每10000例活产4.8例(95%可信区间4.3 - 5.3)。结果表明,从强化前期到强化后期,神经管缺陷患病率在统计学上显著下降(P < 0.05),降幅为51%。通过多种基本食物来源进行叶酸强化已被证明是哥斯达黎加一项成功的公共卫生干预措施。哥斯达黎加的经验可为其他寻求发展和加强其出生缺陷监测及强化计划的国家提供范例。